|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
|
Industry Insight
Randice Altschul delves into some of the expert-led articles within this spring issue of PMPS, including operational efficiency, digitising the supply chain, and how investing in cleanrooms is something companies cannot afford to get wrong.
|
|
|
|
|
|
Implementing Global Standards to Ensure End-to-End GDP Compliance
The Impact of Falsified Medicines
With the arrival of the Falsified Medicines Directive, the impact of this upon pharmaceutical manufacturers should be understood. GS1 UK’s Neil Piper runs through how end-to-end supply chain enhancement can guarantee the authenticity and traceability of medicines.
|
|
|
|
Using Blockchain to Combat Fake Medicine
Pharmaceutical Fraud
Karim Jawhary at Unisys presents the benefits of using blockchain to combat anti-counterfeiting within the pharmaceutical supply chain. However, the unique set of challenges that come with this must not be missed, following several blockchain hacks over recent years.
|
|
|
|
|
Unique Device Identification
Making Your Mark
All companies are required to have unique device identification on medical device packages. Videojet Technologies’ Thierry Protas discusses the benefits of coding and marking in ensuring patient safety.
|
|
|
|
Late-Stage Packaging
Easing Late-Stage Customisation in Pharmaceutical Logistics
The pressure from serialisation legislation on pharmaceutical manufacturers to maintain accurate information on labels is increasing as they look to implement a tamper-evident, flexible solution, states Arndt Neues at Omron.
|
|
|
|
New Packaging Resolutions
An Ageing Issue
In pharmaceutical packaging, a plethora of requirements need to be met to ensure compliance. Solutions can meet both child-resistant and elderly friendly necessities, demonstrates Dr Brad Fain at Intuitive Design Applied Research Institute.
|
|
|
|
The Rise of Small High-Barrier Tubes
Maintaining Security and Sterility
Martina Christiansen at Hoffmann Neopac describes how compliance, user-friendliness, and protection through simplicity are behind the growing demand for small, high-barrier tubes.
|
|
|
|
Saleable Returns Verification
The Importance of Product Master Data
In just a few months, wholesaler distributors will need to implement requirements that are about to be introduced. TraceLink’s Dan Walles highlights how current methods of exchanging product master data information must be re-examined.
|
|
|
|
A Data-Led Approach to Pharma Production and Future Planning
Digitising the Chain
The pharmaceutical industry is constantly changing due to digital revolutions. Rod Schregardus at Access Group analyses the roles automation and data insights in particular play in production, warehousing, and distribution.
|
|
|
|
In Brief
Matchmaker, Matchmaker, Make Me a Match
PMPS’s Industry Advisor, Randice Altschul, contributes an exclusive feature article on her matchmaking tool idea and how this can benefit various stakeholders within the industry.
|
|
|
|
|
Enhancing the Safe Delivery of Medicine with Next-Generation Blister Packs
Finding the Right Solution
With ever-changing healthcare requirements, Honeywell’s Kori Anderson explains how the right packaging resolution can potentially drive operational efficiency and reduce time to market, as well as material, storage, and transport costs.
|
|
|
|
|
Medical Device Development and Commercialisation
Using Short-Run Manufacturing to Solve Design Transfer Challenges
Carl Pullen and Wade Tipton at Cambridge Design Partnership advise on how incorporating short-run manufacturing into product development can assist in overcoming the various challenges that are met within the medical device industry, as well as bringing forward time to market and saving money.
|
|
|
|
Real-Time Monitoring Benefits in Clinical Trials
Building Better Logistics
Digitalising the logistics chain through real-time monitoring is central to developing and maintaining a more secure system. Dirk Wilke at Sensire explores how this can prevent temperature excursion and other environmental harm from damaging medications.
|
|
|
|
The Challenges of Cell and Gene Logistics
A Safer Journey
As life-changing therapies are delivered through the evolving cell and gene sector, optimising supply chain logistics to ensure safe and effective transportation of products is critical to success, states Biocair’s Christopher Good.
|
|
|
|
Optimising Label Recall Processes
Automation: The Definition of Common Sense
Risks can be reduced and prices lowered by considering automated solutions as the answer to costly errors and product recalls caused by outdated manual labelling processes, among other factors, says Craig Jones at PRISYM ID.
|
|
|
|
|
Improving Pharmaceutical Supply Chain Collaboration
The Case for Blockchain Technology
Jason Lacombe at Veratrak examines the road to collaboration success through digitising supply chains and implementing blockchain technology to allow for safer record keeping, despite being overlooked by pharmaceutical companies.
|
|
|
|
|
‘Playing it Safe’ May Be Reducing the Life of Cleanrooms
A Toxic Conversation
The UK Medicines and Healthcare products Regulatory Agency regulations outline how to keep environments clean and safe to ensure compliance. Sue Springett at Teknomek takes a look at how best to tackle this and avoid overspecifying on sterilisation.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Jumo Health Launches Suite of Services to Drive Health Equity in Clinical Trials
NEW HAVEN, Conn. and LOS ANGELES, March 1, 2023 -- Jumo Health, the global provider of age appropriate, culturally sensitive medical education, announced today that, together with the I Choose Life Foundation (ICLF),
it has expanded its health equity service line to include the
recruitment and retention of people of color in clinical trials.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Russia Orange Paper: 1st Quarter 2014
Synergy Research Group
In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia:
1. Fast patient enrollment due to the centralized medical infrastructure.
2. Nearly 100% patient retention
3. GCP trained and certified Investigative Sites generating high quality data
4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >> |
|
 |
Industry Events |
 |
The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023)
12-13 June 2023, Hilton Geneva Hotel & Conference Centre, Geneva, Switzerland
The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023) gathers top-level management from pharmaceutical
companies of manufacturing, primary and secondary packaging, purchasing,
and supply chain and procurement sectors, CMOs and CDMOs leaders, heads
from government and institution on 12-13, June, 2023 in Geneva,
Switzerland.
More info >> |
|
|
